Global Adjunctive Haemostats Market Growth 2023-2029

Global Adjunctive Haemostats Market Growth 2023-2029

The global Adjunctive Haemostats market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Adjunctive Haemostats is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Adjunctive Haemostats is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Adjunctive Haemostats is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Adjunctive Haemostats players cover Baxter (Perclot), Johnson&Johnson (Ethicon Inc.), Biom'Up, BD, Pfizer, C.R.Bard,Inc., Grena Ltd and Schnell Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Adjunctive hemostats are used to assist with the control of intraoperative bleeding. The most common types are flowables, gelatins, thrombins, and oxidized regenerated celluloses (ORCs).

LPI (LP Information)' newest research report, the “Adjunctive Haemostats Industry Forecast” looks at past sales and reviews total world Adjunctive Haemostats sales in 2022, providing a comprehensive analysis by region and market sector of projected Adjunctive Haemostats sales for 2023 through 2029. With Adjunctive Haemostats sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Adjunctive Haemostats industry.

This Insight Report provides a comprehensive analysis of the global Adjunctive Haemostats landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Adjunctive Haemostats portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Adjunctive Haemostats market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Adjunctive Haemostats and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Adjunctive Haemostats.

This report presents a comprehensive overview, market shares, and growth opportunities of Adjunctive Haemostats market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Liquid Substance
Gelatine
Thrombin
Oxidized Regenerated Cellulose
Powder Hemostat

Segmentation by application
Gynecology
Tumors
Cardiovascular
General Surgery

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Baxter (Perclot)
Johnson&Johnson (Ethicon Inc.)
Biom'Up
BD
Pfizer
C.R.Bard,Inc.
Grena Ltd
Schnell Medical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Adjunctive Haemostats market?

What factors are driving Adjunctive Haemostats market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Adjunctive Haemostats market opportunities vary by end market size?

How does Adjunctive Haemostats break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.